================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
SYMMETRY MEDICAL INC.
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.0001 PER SHARE
(Title of Class of Securities)
871546206
(CUSIP Number)
OCTOBER 11, 2006
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[_] Rule 13d-1(b)
[X] Rule 13d-1(c)
[_] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
================================================================================
CUSIP No. 871546206 Page 2 of 11
Schedule 13G
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSON
S.S or I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
HWP Capital Partners II, L.P.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [X]
(b) [_]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF 2,068,300
-------------------------------------------
SHARES BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY -0-
-------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING PERSON 2,068,300
-------------------------------------------
8 SHARED DISPOSITIVE POWER
-0-
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,068,300
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS)
[_]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.9%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
--------------------------------------------------------------------------------
CUSIP No. 871546206 Page 3 of 11
Schedule 13G
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSON
S.S or I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
HWP II, L.P.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [X]
(b) [_]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF 2,068,300
-------------------------------------------
SHARES BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY -0-
-------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING PERSON 2,068,300
-------------------------------------------
8 SHARED DISPOSITIVE POWER
-0-
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,068,300
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS)
[_]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.9%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
--------------------------------------------------------------------------------
CUSIP No. 871546206 Page 4 of 11
Schedule 13G
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSON
S.S or I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
HWP II, LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [X]
(b) [_]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF 2,068,300
-------------------------------------------
SHARES BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY -0-
-------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING PERSON 2,068,300
-------------------------------------------
8 SHARED DISPOSITIVE POWER
-0-
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,068,300
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS)
[_]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.9%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
OO
--------------------------------------------------------------------------------
CUSIP No. 871546206 Page 5 of 11
Schedule 13G
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSON
S.S or I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
(in the capacity described herein)
Robert B. Haas
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [X]
(b) [_]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF 2,068,300
-------------------------------------------
SHARES BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY -0-
-------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING PERSON 2,068,300
-------------------------------------------
8 SHARED DISPOSITIVE POWER
-0-
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,068,300
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS)
[_]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.9%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
--------------------------------------------------------------------------------
CUSIP No. 871546206 Page 6 of 11
Schedule 13G
Item 1. (a) NAME OF ISSUER
Symmetry Medical Inc. (the "COMPANY").
(b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES
220 W. Market Street
Warsaw, Indiana, 46580
Item 2. (a) NAMES OF PERSONS FILING
(i) HWP Capital Partners II, L.P., a Delaware limited
partnership ("HWPCP");
(ii) HWP II, L.P., a Delaware limited partnership ("HWP II"
and the sole general partner of HWPCP);
(iii) HWP II, LLC, a Delaware limited liability company ("HWP
II LLC" and the sole general partner of HWP II); and
(iv) Robert B. Haas ("MR. HAAS" and the managing member of HWP
II LLC) ((i) through (iv) collectively, the "REPORTING
PERSONS").
(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE
The address of the principal business offices of each of the
Reporting Persons is c/o Haas Wheat & Partners, L.P., 300 Crescent
Court, Suite 1700, Dallas, Texas 75201.
(c) CITIZENSHIP
The place of organization of each of the Reporting Persons
(other than Mr. Haas) is Delaware. Mr. Haas is a citizen of the United
States.
(d) TITLE OF CLASS OF SECURITIES
Common Stock, par value $0.0001 per share (the "COMMON STOCK")
(e) CUSIP NUMBER
871546206
Item 3. If this statement is filed pursuant to either Rule 13d-1(b) or
13d-2(b) or (c), check whether the person filing is a:
Not applicable.
CUSIP No. 871546206 Page 7 of 11
Schedule 13G
Item 4. OWNERSHIP.
(a) AMOUNT BENEFICIALLY OWNED:
HWPCP may be deemed to beneficially own 2,068,300 shares of
Common Stock and each of HWP II and HWP II LLC in their capacities as
general partners of HWPCP and HWP II, respectively, may be deemed to
beneficially own 2,068,300 shares of Common Stock as a result of their
voting and dispositive power over the 2,068,300 shares of Common Stock
held by HWPCP.
Mr. Haas may be deemed to beneficially own 2,068,300 shares of
Common Stock as a result of his voting and dispositive power over
2,068,300 shares of Common Stock held by HWPCP.
(b) PERCENTAGE OWNED:
Based on calculations made in accordance with Rule 13d-3, and
there being approximately 34,894,106 shares of Common Stock
outstanding (as reported by the Company in its Quarterly Report on
Form 10-Q for the period ended July 1, 2006 (filed on August 9,
2006)), (i) HWPCP and each of HWP II and HWP II LLC (in their
capacities as general partners of HWPCP and HWP II, respectively) may
be deemed to beneficially own approximately 5.9% of the outstanding
Common Stock and (ii) Mr. Haas may be deemed to beneficially own
approximately 5.9% of the outstanding Common Stock.
(c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS POWER TO DIRECT
THE DISPOSITION:
(i) HWPCP and each of HWP II and HWP II LLC (in their capacities
as general partners of HWPCP and HWP II, respectively) may be deemed
to have sole power to direct the voting and disposition of the
2,068,300 shares of Common Stock held by HWPCP and (ii) Mr. Haas may
be deemed to have sole power to direct the voting and disposition of
the 2,068,300 shares of Common Stock held by HWPCP.
Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
Not applicable.
Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
The general partners and limited partners, as applicable, of HWPCP,
HWP II and HWP II LLC have the right to participate in the receipt of
dividends from, or proceeds from the sale of, the securities held for
the account of such Reporting Persons in accordance with their
ownership interests in such entities.
CUSIP No. 871546206 Page 8 of 11
Schedule 13G
Item 7. IDENTIFICATION AND CLASSIFICATION OF SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
Not applicable.
Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
See Item 2.
Item 9. NOTICE OF DISSOLUTION OF GROUP
Not applicable.
Item 10. CERTIFICATION
(b) The following certification shall be included if the statement is
filed pursuant to ss.240.13d-1(c):
By signing below we certify that, to the best of our knowledge and
belief, the securities referred to above were not acquired and are not
held for the purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction
having that purpose or effect.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
CUSIP No. 871546206 Page 9 of 11
Schedule 13G
SIGNATURES
After reasonable inquiry and to the best of our knowledge and
belief, the undersigned certify that the information set forth in this statement
is true, complete and correct.
Dated as of October 20, 2006
HWP CAPITAL PARTNERS II, L.P.
By: HWP II, L.P., its general partner
By: HWP II, LLC, its general partner
By: /s/ Robert B. Haas
--------------------------------
Name: Robert B. Haas
Title: Managing Member
HWP II, L.P.
By: HWP II, LLC, its general partner
By: /s/ Robert B. Haas
--------------------------------
Name: Robert B. Haas
Title: Managing Member
HWP II, LLC
By: /s/ Robert B. Haas
--------------------------------
Name: Robert B. Haas
Title: Managing Member
ROBERT B. HAAS
/s/ Robert B. Haas
----------------------------------
CUSIP No. 871546206 Page 10 of 11
Schedule 13G
EXHIBIT INDEX
-------------
Exhibit 1. Joint Filing Agreement as required by Rule 13d-1(k)(1) under the
Securities Exchange Act of 1934, as amended (incorporated by
references to Exhibit 1 to the statement on Schedule 13G, dated
as of February 12, 2002, filed by the Reporting Persons).
Exhibit 2. Identity of members of group filing this schedule.
CUSIP No. 871546206 Page 11 of 11
Schedule 13G
EXHIBIT 2
---------
IDENTITY OF MEMBERS OF THE GROUP FILING THIS SCHEDULE
HWP Capital Partners II, L.P.
HWP II, L.P.
HWP II, LLC
Robert B. Haas